Tag: Event
-
IGJC 2026: What Heals the Mind, Heals the Heart Also
On 25-29th of July 2026, a world-leading group of experts in gap junctional biology came together in the halls of the historic University of Padua, Italy, at the International Gap Junction Conference. Over the course of five days, the discussions spanned from the nanoscales of ion channel opening probabilities to clinical symptoms. The physiology and pathology of connexins –…
-
Cellestial Health Presents at the Venture Summit West, California
18th of June 2026; Mountain View, California, USACellestial Health, an innovative pharmaceutical development company offering a paradigm shift approach to Parkinson’s treatments, announces its selection and participation at the 2025 Venture Summit West, which took place June 16–17, 2025 at the Computer History Museun in Mountain View, Silicon Valley. Hosted by youngStartup Ventures, the summit is recognized as…
-
WPC2026: Three Years Later, Somewhere in Arizona
A very special community came together for the World Parkinson’s Congress on 24-27 May in Phoenix, building on from the strong momentum of the 2023 Congress in Barcelona. The Parkinson’s community showed that it:✦ Sings✦ Dances✦ Paints✦ Researches✦ Never stops What other conference have you been to where the whole audience of a plenary hall drums together at the closing…
-
New Beginnings at the BIA Start-Up Festival
On Thursday 21st of May, a panel including Dr Nat Hastings (CEO of Cellestial Health), Dr Jonathan Kwon (CEO of Infinitopes Precision Immunomics), Dr Stasa Stankovic (Co-founder of OvartiX), and Dr Abigail Martin (CEO of InnuneONE), chaired by Inga Deakin of Molten Ventures, discussed what it takes for a new company to be “fit to…
-
Bio Integrates: Built to Compete
On Thursday 14th of May, Dr Nat Hastings, CEO of Cellestial Health contributed to a panel discussion at the annual Bio Integrates conference by Life Sciences Integrates. The key theme of the event focussed on building bridges between key stakeholders in the biotech industry – innovators, investors, and patient groups. The “Built to Compete” panel…
-
Insights from the BMCS Spring Symposium on Medicinal Chemistry
On Thursday 23rd April 2026, Medicinal Chemistry adviser of Cellestial Health, Lewis Pennicott, attended and contributed to the discussion at the 37th BMCS Spring Symposium on Medicinal Chemistry, the heart of the med chem community. He reports: Fantastic day at the Fielder Centre for the #HatfieldMedChem symposium. Staying at the forefront of these technical advancements…
-
Something Different at BioTrinity
The CEO of Cellestial Health Dr Nat Hastings put the usual polished business pitch aside at the BioUK‘s BioTrinity 2026 to discuss an important topic: Whether there is a scientific and economic rationale for viewing the brain as a collection of neurones and synapses. Decades of research demonstrate that:✦ Brain consists of many essential cell…
-
One Nucleus Awards Gala
Last Thursday 19th of March brought the UK-wide life sciences ecosystem leaders together for a very special occasion of the #ONAwards26 celebration at No.11 Cavendish Square in London. It was a great honour to have the project between Cellestial and The University of Manchester, supported by a Parkinson’s UK grant, recognised as one of the finalist entries in the “Best Industry and…
-
Preparing for Success
On 10th of March at Jesus College Cambridge, Sygnature Discovery held a seminar on 𝘚𝘵𝘰𝘳𝘪𝘦𝘴 𝘰𝘧 𝘋𝘳𝘶𝘨 𝘋𝘪𝘴𝘤𝘰𝘷𝘦𝘳𝘺 𝘚𝘶𝘤𝘤𝘦𝘴𝘴, joined by the Cellestial team Nat Hastings and Lewis Pennicott. Examples of rapid development were discussed where lead optimisation to human trial readiness was complete in only 18 months. Programs that utilise time and resource efficiently…
-
All Roads Lead to Rome: Alfasigma Innovation Day
In late February, Cellestial Health team found themselves at a beautiful Alfasigma CDMO facility in Pomezia last week as part of the Proventa International Innovation Day. When should manufacturing, formulation, and clinical supply be considered in the course of therapeutics development?It became clear that no matter what stage the product is, the answer is “Now”.…